CompletedPhase 4

Cardioplegic Protection of the Heart

Sweden40 participantsStarted 2021-06-15

Plain-language summary

This study seek to compare two different solutions used to protect the heart during cardiac surgery. 40 adult patients planned for coronary artery bypass surgery with cardiopulmonary bypass machine assistance will be included in the study. Blood samples from the first 48 hours after surgery will be analyzed together with physical data, x-ray-results, ecg and general outcome after surgery.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients scheduled for non urgent, single procedure coronary artery bypass grafting surgery at Skåne university hospital in Lund Sweden Exclusion Criteria: \*Heart failure (=Left ventricular ejection fraction less than 40 %). * Moderate and severe aortic valve insufficiency. * Type 1 diabetes. * Renal insufficiency (=estimated glomerular filtration rate \<60 mL/min/1,73m2) * Not communicating in Swedish language. * Previous cardiac surgery.

What they're measuring

CKMB

Timeframe: 48 hours after surgery (cross clamp release)

Trial details

NCT IDNCT07386990

SponsorRegion Skane

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-11-18

View on ClinicalTrials.gov More Coronary Artery Bypass Graft (CABG) trials